DESIGN, MOLECULAR DOCKING, MOLECULAR DYNAMICS, AND EVALUATION OF NOVEL LIGANDS TARGETING BETA-2 ADRENERGIC RECEPTOR...

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Computational Chemistry

Background:

• The beta-2 adrenergic receptor (β2AR) plays a crucial role in regulating bronchoconstriction.
• Asthma treatment often involves targeting β2AR to achieve bronchodilation.
• Developing novel β2AR agonists with improved efficacy and selectivity is an ongoing therapeutic goal.

Purpose of the Study:

• To design and computationally evaluate novel ligands targeting the β2AR.
• To assess the binding affinities and interactions of synthesized compounds with the β2AR.
• To identify potential new drug candidates for asthma therapy.

Main Methods:

• Molecular docking simulations using GOLD software were employed.
• Binding affinities of synthesized compounds (Compound 1, Compound 5) and salbutamol were evaluated.
• Analysis of receptor-ligand interactions and identification of key binding residues.

Main Results:

• Compounds 1 and 5 exhibited strong binding to the β2AR, comparable to the reference drug salbutamol.
• Key residues (SER 207, PHE 289, LYS 305, ASP 192) were identified as critical for stabilizing interactions.
• Functional groups like NO2 and NC in the novel compounds enhanced binding affinity.

Conclusions:

• Compounds 1 and 5 are promising candidates for further development as β2 agonists.
• Structural modifications can potentially optimize β2AR binding and therapeutic potential.
• The study provides insights into β2AR-ligand interactions for designing future asthma therapeutics.